化膿性汗腺炎
- TOP
- 化膿性汗腺炎
化膿性汗腺炎について
化膿性汗腺炎（hidradenitis suppurativa）は慢性・炎症性・再発性・消耗性の皮膚毛包性疾患であり、患者の生活の質を著しく障害します。近年、本疾患は自然免疫の活性化を背景に終毛の毛包を中 心として生じる慢性炎症性毛包性疾患であることが分かってきたが、発症機序は不明な点が多く、化膿性汗腺炎の病態生理について研究を継続して行います。
掲載論文
- Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan. J Dermatol. 2022 Apr;49(4):411-421. doi: 10.1111/1346-8138.16297. Epub 2022 Jan 17. PMID: 35040156; PMCID: PMC9305509.
- Hayama K, Fujita H, Hashimoto T, Terui T. Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard. Acta Derm Venereol. 2022 Jan 18;102:adv00632. doi: 10.2340/actadv.v101.1013. PMID: 34935991; PMCID: PMC9558336.
- Nishimori N, Hayama K, Kimura K, Fujita H, Fujiwara K, Terui T. A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa. Acta Derm Venereol. 2020 Oct 6;100(17):adv00283. doi: 10.2340/00015555-3632. PMID: 32926179; PMCID: PMC9274921.
- Hayama K, Fujita H, Hashimoto T, Terui T; Japanese HS Research Group. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries. J Dermatol. 2020 Jul;47(7):743-748. doi: 10.1111/1346-8138.15378. Epub 2020 May 22. PMID: 32441411; PMCID: PMC7818453.